Cas:118525-35-2 Sagittatoside A manufacturer & supplier

Chemical Name:Sagittatoside A

CAS.NO:118525-35-2

Synonyms:sagittatoside A;5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4-oxo-4H-chromen-3-yl 6-deoxy-2-O-β-D-glucopyranosyl-α-L-mannopyranoside;4H-1-Benzopyran-4-one, 3-[(6-deoxy-2-O-β-D-glucopyranosyl-α-L-mannopyranosyl)oxy]-5,7-dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-;SagittatosideA

Molecular Formula:C₃₃H₄₀O₁₅

Molecular Weight:676.662

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:933.3±0.0 °C at 760 mmHg

Density:1.6±0.0 g/cm3

Index of Refraction:1.679

PSA:238.20000

Exact Mass:676.236694

LogP:2.71

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like sagittatoside A chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,SagittatosideA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5,7-Dihydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4-oxo-4H-chromen-3-yl 6-deoxy-2-O-β-D-glucopyranosyl-α-L-mannopyranoside Use and application,SagittatosideA technical grade,usp/ep/jp grade.

Related News: Toxic forever chemicals have no place in personal care products,” Scott Faber, EWG’s senior vice president of government affairs. “PFAS have been linked to serious health problems, including cancer and harm to the reproductive and immune systems. EWG applauds Sen. Collins and Rep. Dingell for introducing the No PFAS in Cosmetics Act. Sagittatoside A manufacturer Toxic forever chemicals have no place in personal care products,” Scott Faber, EWG’s senior vice president of government affairs. “PFAS have been linked to serious health problems, including cancer and harm to the reproductive and immune systems. EWG applauds Sen. Collins and Rep. Dingell for introducing the No PFAS in Cosmetics Act. Sagittatoside A supplier ICIG companies currently employ more than 3,000 people and operate 15 manufacturing facilities in Europe and the United States. Sagittatoside A vendor ICIG companies currently employ more than 3,000 people and operate 15 manufacturing facilities in Europe and the United States. Sagittatoside A factory As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company��s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.